Enhanced oral bioavailability and hepatoprotective activity of thymoquinone in the form of phospholipidic nano-constructs

References

• Ahmed MF, Rao AS, Thayyil H, et al. Role of melia azedarach leaf extract in paracetamol induced hepatic damage in rats. Pharmacogn J. 2011; 3(21):60–64.
   Google Scholar
• Singh A, Ahmad I, Akhter S, et al. Nanocarrier based formulation of Thymoquinone improves oral delivery: stability assessment, in vitro and in vivo studies. Colloids Surf B Biointerfaces. 2013;1(102):822–832.
   Google Scholar
• Asrani SK, Devarbhavi H, Eaton J, et al. Burden of liver diseases in the world. J Hepatol. 2019;70(1):151–171.
   Google Scholar
• Darakhshan S, Pour AB, Colagar AH, et al. Thymoquinone and its therapeutic potentials. Pharmacol Res. 2015;1(95):138–158.
   Google Scholar
• Negi P, Rathore C, Sharma G, et al. Thymoquinone a potential therapeutic molecule from the plant nigella sativa: role of colloidal carriers in its effective delivery. Recent Pat Drug Deliv Formul. 2018;12(1):3–22.
   PubMedGoogle Scholar
• Ballout F, Habli Z, Rahal ON, et al. Thymoquinone-based nanotechnology for cancer therapy: promises and challenges. Drug Discov Today. 2018;23(5):1089–1098.
   PubMed Web of Science ®Google Scholar
• Kalam MA, Raish M, Ahmed A, et al. Oral bioavailability enhancement and hepatoprotective effects of thymoquinone by self-nanoemulsifying drug delivery system. Mater Sci Eng C. 2017;1(76):319–329.
   Google Scholar
• Farkhondeh T, Samarghandian S, Shahri AM, et al. The neuroprotective effects of thymoquinone: A review. Dose-Response. 2018;16(2):1559325818761455.
   Web of Science ®Google Scholar
• Shahid F, Farooqui Z, Khan AA, et al. Oral Nigella sativa oil and thymoquinone administration ameliorates the effect of long-term cisplatin treatment on the enzymes of carbohydrate metabolism, brush border membrane, and antioxidant defense in rat intestine. Naunyn-Schmiedeberg’s Arch Pharmacol. 2018;391(2):145–157.
   Google Scholar
• Alkharfy KM, Ahmad A, Raish M, et al. Thymoquinone modulates nitric oxide production and improves organ dysfunction of sepsis. Life Sci. 2015;5(143):131–138.
   Google Scholar
• Patra JK, Das G, Fraceto LF, et al. Nano based drug delivery system: recentdevelopment and future prospect. J Nanobiotechnology. 2018;71:2–33.
   Google Scholar
• Sayeed S, Imam SS, Najmi AK, et al. Nonionic surfactant based thymoquinone loaded nanoproniosomal formulation: in vitro physicochemical evaluation and in vivo hepatoprotective efficacy. Drug Dev Ind Pharm. 2017;43(9):1413–1420.
   PubMed Web of Science ®Google Scholar
• Salvi VR, Pawar P. Nanostructured lipid carriers (NLC) system: A novel drug targeting carrier. J Drug Delivery Sci Technol. 2019;22:255–267.
   Google Scholar
• Pardeike J, Schwabe K, Müller RH. Influence of nanostructured lipid carriers (NLC) on the physical properties of the Cutanova Nanorepair Q10 cream and the in vivo skin hydration effect. Int J Pharm. 2010;396(1–2):166–173.
   PubMedGoogle Scholar
• Raza K, Singh B, Singla N, et al. Nano-lipoidal carriers of isotretinoin with anti-aging potential: formulation, characterization and biochemical evaluation. J Drug Target. 2013;21(5):435–442.
   PubMed Web of Science ®Google Scholar
• Porter CJ, Charman WN. Intestinal lymphatic drug transport: an update. Adv Drug Deliv Rev. 2001;50(1–2):61–80.
   PubMed Web of Science ®Google Scholar
• Raza K, Singh B, Lohan S, et al. Nano-lipoidal carriers of tretinoin with enhanced percutaneous absorption, photostability, biocompatibility and anti-psoriatic activity. Int J Pharm. 2013;456(1):65–72.
   PubMed Web of Science ®Google Scholar
• Abdelwahab SI, Sheikh BY, Taha MM, et al. Thymoquinone-loaded nanostructured lipid carriers: preparation, gastroprotection, in vitro toxicity, and pharmacokinetic properties after extravascular adginistration. Int J Nanomedicine. 2013;8:2163.
   PubMed Web of Science ®Google Scholar
• Ng WK, Saiful YL, Yap LH, et al. Thymoquinone-loaded nanostructured lipid carrier exhibited cytotoxicity towards breast cancer cell lines (MDA-MB-231 and MCF-7) and cervical cancer cell lines (HeLa and SiHa). Bio Med Res Int. 2015;2015:263131.
   Google Scholar
• Khurana RK, Bansal AK, Beg S, et al. Enhancing biopharmaceutical attributes of phospholipid complex-loaded nanostructured lipidic carriers of mangiferin: systematic development, characterization and evaluation. Int J Pharm. 2017;518(1–2):289–306.
   PubMed Web of Science ®Google Scholar
• Singh B, Kapil R, Nandi M, et al. Developing oral drug delivery systems using formulation by design: vital precepts, retrospect and prospects. Expert Opin Drug Deliv. 2011;8(10):1341–1360.
   PubMed Web of Science ®Google Scholar
• Ferreira SC, Bruns RE, Ferreira HS, et al. Box-Behnken design: an alternative for the optimization of analytical methods. Anal Chim Acta. 2007;10(2):179–186.
   Google Scholar
• Rakić T, Kasagić-Vujanović I, Jovanović M, et al. Comparison of full factorial design, central composite design, and box-behnken design in chromatographic method development for the determination of fluconazole and its impurities. Anal Lett. 2014;47(8):1334–1347.
   Web of Science ®Google Scholar
• Negi P, Singh B, Sharma G, et al. Biocompatible lidocaine and prilocaine loaded-nanoemulsion system for enhanced percutaneous absorption: qbD-based optimisation, dermatokinetics and in vivo evaluation. J Microencapsul. 2015;32(5):419–431.
   PubMed Web of Science ®Google Scholar
• Souto EB, Wissing SA, Barbosa CM, et al. Development of a controlled release formulation based on SLN and NLC for topical clotrimazole delivery. Int J Pharm. 2004;278(1):71–77.
   PubMed Web of Science ®Google Scholar
• Rathore C, Upadhyay NK, Sharma A, et al. Phospholipid nanoformulation of thymoquinone with enhanced bioavailability: development, characterization and anti-inflammatory activity. J Drug Delivery Sci Technol. 2019;52:316–324.
   Web of Science ®Google Scholar
• Raza K, Singh B, Singal P, et al. Systematically optimized biocompatible isotretinoin-loaded solid lipid nanoparticles (SLNs) for topical treatment of acne. Colloids Surf B Biointerfaces. 2013;105:67–74.
   PubMed Web of Science ®Google Scholar
• Negi P, Singh B, Sharma G, et al. Phospholipid microemulsion-based hydrogel for enhanced topical delivery of lidocaine and prilocaine: qbD-based development and evaluation. Drug Deliv. 2014; DOI:10.3109/10717544.2014.923067.
   PubMed Web of Science ®Google Scholar
• Negi P, Aggarwal M, Sharma G, et al. Niosome-based hydrogel of resveratrol for topical applications: an effective therapy for pain related disorder(s). Biomed Pharmacother. 2017;88:480–487.
   PubMed Web of Science ®Google Scholar
• Szűts A, Budai-Szűcs M, Erős I, et al. Study of gel-forming properties of sucrose esters for thermosensitive drug delivery systems. Int J Pharm. 2010;383(1–2):132–137.
   PubMedGoogle Scholar
• Chadha R, Saini A, Arora P, et al. Multicomponent solids of lamotrigine with some selected coformers and their characterization by thermoanalytical, spectroscopic and X-ray diffraction methods. CrystEngComm. 2011;13(20):6271–6284.
   Web of Science ®Google Scholar
• Jain AK, Thanki K, Jain S. Solidified self-nanoemulsifying formulation for oral delivery of combinatorial therapeutic regimen: part I. formulation development, statistical optimization, and in vitro characterization. Pharm Res. 2014;1(31–4):923–945.
   Google Scholar
• Rathore C, Jain N, Garg N, et al. Polysaccharide-microsponge based matrix tablet for colon targeting of ketoprofen: in vitro and in vivo evidence. Int J Pharm Sci Res. 2017 1;8(10):4250–4260.
   Web of Science ®Google Scholar
• Bapat P, Ghadi R, Chaudhari D, et al. Tocophersolan stabilized lipid nanocapsules with high drug loading to improve the permeability and oral bioavailability of curcumin. Int J Pharm. 2019 Apr;5(560):219–227.
   Google Scholar
• Pathan SA, Jain GK, Zaidi SM, et al. Stability‐indicating ultra‐performance liquid chromatography method for the estimation of thymoquinone and its application in biopharmaceutical studies. Biomed Chromatogr. 2011;25(5):613–620.
   PubMed Web of Science ®Google Scholar
• Das S, Roy P, Auddy RG, et al. Silymarin nanoparticle prevents paracetamol-induced hepatotoxicity. Int J Nanomedicine. 2011;6:1291.
   PubMed Web of Science ®Google Scholar
• Baravalia Y, Vaghasiya Y, Chanda S. Hepatoprotective effect of woodfordia fruticosa kurz flowers on diclofenac sodium induced liver toxicity in rats. Asian Pac J Trop Med. 2011;4(5):342–346.
   PubMed Web of Science ®Google Scholar
• Danaei M, Dehghankhold M, Ataei S, et al. Impact of particle size and polydispersity index on the clinical applications of lipidic nanocarrier systems. Pharmaceutics. 2018;10:1–17.
   Web of Science ®Google Scholar
• Shah M, Agrawal Y. Ciprofloxacin hydrochloride-loaded glyceryl monostearate nanoparticle: factorial design of Lutrol F68 and Phospholipon 90G. J Microencapsul. 2012;29(4):331–343.
   PubMed Web of Science ®Google Scholar
• Bunjes H, Koch MH, Westesen K. Effects of surfactants on the crystallization and polymorphism of lipid nanoparticles. Mol Organ Interfaces. 2002;121:7–10.
   Google Scholar
• Hasan AA, Sabry SA, Abdallah MH, et al. Formulation and in vitro characterization of poly (DL-lactide-co-glycolide)/eudragit RLPO or RS30D nanoparticles as an oral carrier of levofloxacin hemihydrate. Pharm Dev Technol. 2016;21(6):655–663.
   PubMed Web of Science ®Google Scholar
• Kovačević AB, Müller RH, Savić SD, et al. Solid lipid nanoparticles (SLN) stabilized with polyhydroxy surfactants: preparation, characterization and physical stability investigation. Colloids Surf A Physicochem Eng Asp. 2014;444:15–25.
   Web of Science ®Google Scholar
• Zirak MB, Pezeshki A. Effect of surfactant concentration on the particle size, stability and potential zeta of beta carotene nano lipid carrier. Int J Curr Microbiol Appl Sci. 2015;4(9):924–932.
   Google Scholar
• Bashiri S, Ghanbarzadeh B, Ayaseh A, et al. Preparation and characterization of chitosan-coated nanostructured lipid carriers (CH-NLC) containing cinnamon essential oil for enriching milk and anti-oxidant activity. LWT. 2019;13:108836.
   Google Scholar
• Carbinatto FM, de Castro AD, Evangelista RC, et al. Insights into the swelling process and drug release mechanisms from cross-linked pectin/high amylose starch matrices. Asian J Pharm Sci. 2014;9(1):27–34.
   Google Scholar
• Uprit S, Sahu RK, Roy A, et al. Preparation and characterization of minoxidil loaded nanostructured lipid carrier gel for effective treatment of alopecia. Saudi Pharm J. 2013;21(4):379–385.
   PubMed Web of Science ®Google Scholar
• Wang K, Qi J, Weng T, et al. Enhancement of oral bioavailability of cyclosporine A: comparison of various nanoscale drug-delivery systems. Int J Nanomedicine. 2014;9:4991.
   PubMed Web of Science ®Google Scholar
• Singh N, Khullar N, Kakkar V, et al. Hepatoprotective effects of sesamol loaded solid lipid nanoparticles in carbon tetrachloride induced sub‐chronic hepatotoxicity in rats. Environ Toxicol. 2016;31(5):520–532.
   PubMed Web of Science ®Google Scholar
• Aditya NP, Shim M, Lee I, et al. Curcumin and genistein co-loaded nanostructured lipid carriers: in vitro digestion and antiprostate cancer activity. J Food Agr Food Chem. 2013;61:1878–1883.
   PubMed Web of Science ®Google Scholar
• Son GH, Na YG, Huh HW, et al. Systemic design and evaluation of ticagrelor-loaded nanostructured lipid carriers for enhancing bioavailability and antiplatelet activity. Phjarmaceutics. 2019;11:1–18.
   Web of Science ®Google Scholar
• Algul D, Duman G, Ozdemir S, Preformulation, Characterization, and. In vitro release studies of caffeine-loaded solid lipid nanoparticles. J Cosmet Sci. 2018;69:165–173.
   PubMed Web of Science ®Google Scholar